Patents by Inventor Ho Yeong Song

Ho Yeong Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED AND AFFINITY-MATURED ANTI-C-MET ANTIBODY AND USES THEREOF
    Publication number: 20140294814
    Abstract: Provided is a humanized and affinity-matured anti-c-Met antibody, a pharmaceutical composition including the antibody, and a method of preventing and/or treating c-Met-related disease using the antibody.
    Type: Application
    Filed: March 31, 2014
    Publication date: October 2, 2014
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: SEUNG HYUN LEE, KYUNG AH KIM, KWANG HO CHEONG, HO YEONG SONG
  • ANTI C-MET ANTIBODY AND USES THEREOF
    Publication number: 20140154251
    Abstract: An anti-c-Met antibody or antibody fragment and pharmaceutical composition comprising same, as well as a method for preventing and treating cancer by administering the antibody to a subject are provided.
    Type: Application
    Filed: November 15, 2013
    Publication date: June 5, 2014
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Seung Hyun LEE, Geun Woong Kim, Kyung Ah Kim, Hye Won Park, Ho Yeong Song, Young Mi Oh, Saet Byoul Lee, Ji Min Lee, Kwang Ho Cheong, Yun Ju Jeong, Mi Young Cho, Jae Hyun Choi, Yun Jeong Song, Yoon Aa Choi
  • Therapeutic applications of mFLINT polypeptides
    Publication number: 20040167074
    Abstract: Mature FLINT protein (mFLINT) binds FasL and LIGHT, and prevents FasL-Fas interaction. mFLINT inhibits FasL-Fas-mediated apoptotic and proinflammatory activity, and is useful in treating disorders associated with abnormal apoptosis and inflammation. The invention provides the amino acid and nucleotide sequences of FLINT and mature FLINT. The preparation and characterization of transgenic animals that express FLINT is disclosed. Therapeutic compositions and methods of treatment utilizing mFLINT also are provided.
    Type: Application
    Filed: March 4, 2004
    Publication date: August 26, 2004
    Inventors: Thomas Frank Bumol, Shenshen Dou, Andrew Lawrence Glasebrook, Songqing Na, Ho Yeong Song, Steven Harold Zuckerman
  • Novel secreted proteins and their uses
    Publication number: 20040142333
    Abstract: The present invention provides nucleic acid sequences encoding novel human proteins. These novel nucleic acids are useful for constructing the claimed DNA vectors and host cells of the invention and for preparing the claimed recombinant proteins and antibodies that are useful in the claimed methods and medical uses.
    Type: Application
    Filed: March 27, 2003
    Publication date: July 22, 2004
    Inventors: Deshun Lu, Ho Yeong Song, Eric Wen Su, He Wang
  • Treating t-cell mediated diseases by modulating dr6 activity
    Publication number: 20040043022
    Abstract: Novel methods are provided for the treatment or prevention of T cell mediated conditions in a mammal that comprise administering to said mammal a therapeutically effective amount of a pharmaceutical composition comprising at least one DR6 agonist or DR6 antagonist.
    Type: Application
    Filed: October 16, 2002
    Publication date: March 4, 2004
    Inventors: Josef Georg Heuer, Jinqi Liu, Songqing Na, Ho Yeong Song, Derek Di Yang